Back

The influence of remnant cholesterol on ischemic stroke and its subtypes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Epidemiology of stroke in patients with heart disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Suifeng Liu

Zhongshan Hospital Xiamen University, Xiamen (China)

6 More presentations in this session

Presentation thumbnail
Cardiovascular outcomes in patients with newly diagnosed atrial fibrillation and previous stroke: a plausible impact of stroke-heart syndrome using longitudinal data from the GLORIA-AF registry
Doctor S. Lam (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Echocardiographic signs of atrial cardiopathy and MRI-detected silent brain infarcts in a middle-aged cohort: the Akershus Cardiac Examination 1950 Study
Mr H. Ihle-Hansen (Gjettum, NO)
Abstract Slides Video
Presentation thumbnail
High ABCD2-score after transient ischemic attack is associated with a two-fold higher stroke-rate during long-term follow-up
Miss K. Al-Chaer (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Predictors of Ischemic Stroke in a cohort of patients with Chagas Cardiomyopathy: the CLOT-Chagas study
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides
Presentation thumbnail
The very long-term risk of stroke after acute coronary syndrome and geographic differences. The ABC-10* study on heart disease.
Doctor G. Berton (Conegliano, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology of stroke in patients with heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses
thumbnail
Congress Presentation
Remnant cholesterol and cardiovascular and all-cause mortality in Korean adults
thumbnail
Congress Presentation
Remnant cholesterol is a predictor for all-cause mortality in coronary artery disease patients independent of the total ApoB-particle count

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources